NCT00530257View on ClinicalTrials.gov

Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Placebo

Placebo (sugar pill)

DRUG

OROS-methylphenidate

18 mg to 54 mg once a day for 1 week

Trial Locations (1)

19104

The Children's Hospital of Philadelphia, Philadelphia

All Listed Sponsors
collaborator

Ortho-McNeil Janssen Scientific Affairs, LLC

INDUSTRY

lead

Children's Hospital of Philadelphia

OTHER

NCT00530257 - Study of the Effects of Osmotic-Release Oral System (OROS) Methylphenidate (Concerta) on Attention and Memory | Biotech Hunter | Biotech Hunter